Dr Casey Sehri Prammanasudh, MD | |
178 W Street Rd, Feasterville Trevose, PA 19053-7817 | |
(215) 322-5042 | |
Not Available |
Full Name | Dr Casey Sehri Prammanasudh |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 9 Years |
Location | 178 W Street Rd, Feasterville Trevose, Pennsylvania |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114314622 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | MD23678 (Maine) | Secondary |
207V00000X | Obstetrics & Gynecology | BP10053067 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Mary Medical Center | Langhorne, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Trinity Health Mid-atlantic Medical Group | 7416861885 | 239 |
News Archive
Environmental factors may be a contributory cause in the development of some childhood cancers, leading scientists have revealed.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, will deliver four poster presentations on its compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
An international team of scientists, led by researchers from A*STAR's Genome Institute of Singapore (GIS), Institute of Medical Biology (IMB), and Bioinformatics Institute (BII), and P&G, have completed the first comprehensive genomic and biologic study of all species of Malassezia, one of the top skin disease-causing microbes.
The Swiss National Science Foundation is launching the National Research Programme "Smarter Health Care". 29 research teams will be looking for ways of providing better and more cost-efficient health services for people with chronic diseases.
› Verified 8 days ago
Entity Name | Trinity Health Mid-atlantic Medical Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093771271 PECOS PAC ID: 7416861885 Enrollment ID: O20040326000613 |
News Archive
Environmental factors may be a contributory cause in the development of some childhood cancers, leading scientists have revealed.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, will deliver four poster presentations on its compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
An international team of scientists, led by researchers from A*STAR's Genome Institute of Singapore (GIS), Institute of Medical Biology (IMB), and Bioinformatics Institute (BII), and P&G, have completed the first comprehensive genomic and biologic study of all species of Malassezia, one of the top skin disease-causing microbes.
The Swiss National Science Foundation is launching the National Research Programme "Smarter Health Care". 29 research teams will be looking for ways of providing better and more cost-efficient health services for people with chronic diseases.
› Verified 8 days ago
Entity Name | Greater Philadelphia Health Action Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1205140902 PECOS PAC ID: 9537064977 Enrollment ID: O20110602000389 |
News Archive
Environmental factors may be a contributory cause in the development of some childhood cancers, leading scientists have revealed.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, will deliver four poster presentations on its compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
An international team of scientists, led by researchers from A*STAR's Genome Institute of Singapore (GIS), Institute of Medical Biology (IMB), and Bioinformatics Institute (BII), and P&G, have completed the first comprehensive genomic and biologic study of all species of Malassezia, one of the top skin disease-causing microbes.
The Swiss National Science Foundation is launching the National Research Programme "Smarter Health Care". 29 research teams will be looking for ways of providing better and more cost-efficient health services for people with chronic diseases.
› Verified 8 days ago
Entity Name | St Mary Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083622286 PECOS PAC ID: 4688588064 Enrollment ID: O20190404000590 |
News Archive
Environmental factors may be a contributory cause in the development of some childhood cancers, leading scientists have revealed.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, will deliver four poster presentations on its compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
An international team of scientists, led by researchers from A*STAR's Genome Institute of Singapore (GIS), Institute of Medical Biology (IMB), and Bioinformatics Institute (BII), and P&G, have completed the first comprehensive genomic and biologic study of all species of Malassezia, one of the top skin disease-causing microbes.
The Swiss National Science Foundation is launching the National Research Programme "Smarter Health Care". 29 research teams will be looking for ways of providing better and more cost-efficient health services for people with chronic diseases.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Casey Sehri Prammanasudh, MD 41 University Dr Ste 300, Newtown, PA 18940-1873 Ph: (215) 710-7037 | Dr Casey Sehri Prammanasudh, MD 178 W Street Rd, Feasterville Trevose, PA 19053-7817 Ph: (215) 322-5042 |
News Archive
Environmental factors may be a contributory cause in the development of some childhood cancers, leading scientists have revealed.
NovaBay Pharmaceuticals, Inc., a clinical stage biotechnology company developing first-in-class, anti-infective compounds for the treatment and prevention of antibiotic-resistant infections, will deliver four poster presentations on its compounds at the 50th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
An international team of scientists, led by researchers from A*STAR's Genome Institute of Singapore (GIS), Institute of Medical Biology (IMB), and Bioinformatics Institute (BII), and P&G, have completed the first comprehensive genomic and biologic study of all species of Malassezia, one of the top skin disease-causing microbes.
The Swiss National Science Foundation is launching the National Research Programme "Smarter Health Care". 29 research teams will be looking for ways of providing better and more cost-efficient health services for people with chronic diseases.
› Verified 8 days ago
Shruti Sharma, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 178 W Street Rd, Feasterville Trevose, PA 19053 Phone: 215-332-5042 | |
Afua Mintah, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 178 W Street Rd, Feasterville Trevose, PA 19053 Phone: 215-322-5042 Fax: 215-322-5043 | |
Gennadiy Ivanov, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 520 Bustleton Pike, Feasterville Trevose, PA 19053 Phone: 215-631-3873 Fax: 215-631-3899 |